Qureverin Tablet (Propiverine Hydrochloride)

Adult dose

Adults: Administer propiverine hydrochloride 20 mg orally once daily after meals. The dose may be adjusted as appropriate according to symptoms; if the effect is insufficient and there are no safety concerns, 20 mg may be taken up to 2 times daily.

This medication may not be suitable for certain patients. Patients who have had allergic reactions to this medication or its components should not take it. Additionally, this medication should not be administered to patients with blocked stomach or intestines, as it can inhibit movement of the stomach muscles and worsen symptoms. Patients with weak gastrointestinal function or excessively relaxed intestines may also experience worsening symptoms due to the anticholinergic effects of this medication. Patients with difficulty urinating should be cautious, as reduced contractions of the bladder muscles can worsen symptoms. Patients with glaucoma due to increased pressure in the eye should not take this medication. Patients with severe myasthenia gravis or severe heart disease may also have worsened symptoms due to this medication. Patients with severe inflammation or disorders in the colon, significantly reduced liver function, or a history of arrhythmias should avoid this medication. Moreover, this medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. When using this medication, extra caution should be exercised in certain situations such as urinary difficulties, liver or kidney dysfunction, Parkinson's disease, hyperthyroidism, and elderly patients. Especially in the elderly, as liver and kidney function may be weak, starting at a lower dose is safer. This medication may cause symptoms such as mental confusion, hallucinations, and nonsensical speech, and it should be discontinued immediately if these symptoms occur. Severe constipation or abdominal bloating may occur in the gastrointestinal system, so caution is needed. There is a possibility of heart irregularities, and if symptoms such as palpitations or irregular heartbeats occur, the medication should be stopped. Severe side effects such as thrombocytopenia, kidney dysfunction, skin rash, acute glaucoma attacks, liver dysfunction, muscle pain have also been reported, thus observation is required. When taking this medication, one must check for other diseases that have similar symptoms, and in cases of lower urinary tract obstruction, treatment of that condition should take precedence. Drowsiness, dizziness, and vision disturbances may occur, so driving or operating dangerous machinery should be avoided. This medication may increase side effects when taken with other anticholinergics, certain antidepressants, schizophrenia treatments, and MAO inhibitors, so caution is advised. Women who are pregnant or may become pregnant should avoid this medication as its safety has not been established, and it is also advisable for breastfeeding women to discontinue nursing during treatment. The safety of this medication for children has not been confirmed, so it should not be administered to them. In case of overdose, symptoms such as confusion, convulsions, gait disturbances, urinary retention, irregular heartbeats, and increased blood pressure may occur, so immediate medical attention is necessary. This medication should be stored out of the reach of children, and transferring to another container may not be good for maintaining quality, so it should be avoided.

• Hallucinations
• delusions
• paralytic ileus
• constipation
• abdominal distension
• palpitations
• ectopic beats
• bradycardia
• QT prolongation
• ventricular tachycardia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature) to preserve the efficacy of the medication.

Appearance

White flat round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle